Factors associated with disease evolution in Greek patients with inflammatory bowel disease

BMC Gastroenterology

Volumn 6, Issue , 2006, Pages

  Chatzicostas, Constantinos ^a   Roussomoustakaki, Maria ^b   Potamianos, Spiros ^b   Paspatis, Gregorios ^c   Mouzas, Ioannis ^b   Romanos, John ^b   Mavrogeni, Helen ^a   Kouroumalis, Elias ^b  

^a General Hospital of Rethymnon   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c Venizelion General Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; CIGARETTE SMOKING; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FOLLOW UP; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROBABILITY; PROCTITIS; RISK ASSESSMENT; RISK FACTOR; ULCERATIVE COLITIS;

ADULT; BEHAVIOR THERAPY; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PROCTITIS; RISK FACTORS; SMOKING;

EID: 33748289478     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-6-21     Document Type: Article

References (66)

1. Greenstein AJ, Lackman P, Sachar DB, Springhorn J, Heimann T, Janowitz HID, Aufses AH Jr. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988, 29:588-592.
2. Sachar DB, Andrews HA, Farmer RG, Pallone F, Pena AS, Prantera C: Proposed classification of patient subgroups in Crohn's disease. Gastroenterol Intern 1992, 5:141-154.
3. Greenway SE, Buckmire MA, Marroquin C, Jadon L, Rolandelli RH: Clinical subtypes of Crohn's disease according to surgical outcome. J Gastrointest Surg 1999, 3:145-151.
4. Steinhart AH, Girgrah N, McLeod RS: Reliability of a Crohn's disease clinical classification scheme based on disease behaviour. Inflamm Bowel Dis 1998, 4:228-234.
5. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR: A simple classification of Crohn's disease: report of the working party of the world congress of gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000, 6:8-15.
6. Achkar JB, Brzezinski A: Interobserver agreement for disease behaviour phenotype in Crohn's disease. Gastroenterology 2002, 122(suppl):W1293.
7. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El, Yafi FA, Belaiche J:Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001, 49:777-782.
8. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J: Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD I5 genotype. Gut 2003, 52:552-557.
9. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP: Long-term evolution of disease behaviour of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
10. Freeman HJ: Natural history and clinical behaviour of Crohn's disease extending beyond two decades. J Clin Gastroenterol 2003, 37:216-219.
11. Smith BR, Arnott RID, Drummond HE, Nimmo ER, Satsangi J: Disease localization, Anti-Saccharomyces cerevisiae antibody, and NOD2/CARD I5 genotype influence the progression of disease behaviour in Crohn's disease. Inflamm Bowel Dis 2004, 10:521-528.
12. Farmer RG, Easley KA, Rankin GB: Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993, 38:1137-1146.
13. Ayres RC, Gillen CD, Walmsley RS, Allan RN: Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gostroenterol Hepatol 1996, 6:555-558.
14. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V: Changes in extent of ulcerative colitis. A study on the course and prognostic factors. Scand J Gastroenterol 1996, 31:260-266.
15. Powell-Tuck J, Ritchie JK, Lennard-Jones JE: The prognosis of idiopathic proctitis. Scand J Gastroenterol 1977, 12:727-732.
16. Sinclair TS, Brunt PW, Mowatt NAG: Non-specific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983, 85:1-11.
17. Niv Y, Bat L, Ron E, Theodor E: Change in the extent of colonic involvement in ulcerative colitis: a colonoscopic study. Am J Gastroenterol 1987, 82:1046-1051.
18. Samuelsson SM, Ekbom A, Zack M, Helmick CG, Adami HO: Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study. Gut 1991, 32:1526-1530.
19. Moum B, Ekbom A, Vatn MH, Elgjo K: Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 1999, 94:1564-1569.
20. Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P, Ferraris L, Panelli MR, Prada A, Sostegni R, de Franchis R: The natural history of ulcerative proctitis: A multicenter, retrospective study. Am J Gastroenterol 2000, 95:469-73.
21. Pica R, Paoluzi OA, lacopini F, Marcheggiano A, Crispino P, Rivera M, Bella A, Consolazio A, Paoluzi P: Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis. Inflamm Bowel Dis 2004, 10:731-6.
22. Manousos ON, Giannadaki E, Mouzas IA, Tzardi M, Koutroubakis I, Skordilis P, Vassilakis S, Kouroumalis E, Vlachonikolis IG: Ulcerative colitis is as common in Crete as in Northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol 1996, 8:893-8.
23. Manousos ON, Koutroubakis I, Potamianos S, Roussomoustakaki M, Gourtsoyiannis N, Vlachonikolis IG: A prospective epidemiologic study of Crohn's disease in Heraklion, Crete. Scand J Gastroenterol 1996, 31:599-603.
24. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blakenstein M: Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996, 39:690-7.
25. Lennard-jones JE, Shivananda S, the EC-IBD study group: Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol 1997, 9:353-359.
26. Witte J, Shivananda E, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi A, Tsianos EV, Mouzas I, Schultz TB, Monteiro E, Clofent J, Odes S, Limonard CB, Stockbrugger RW, Russel MG: Disease outcome in inflammatory bowel disease: Mortality, morbidity, and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 2000, 35:1272-1277.
27. Swartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ: The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002, 122:875-880.
28. Munkholm P, Langholz E, Davidsen M, Binder V: Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995, 30:699-706.
29. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
30. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
31. Cox DR: Regression models and life tables. J R Stat Soc 1972, 34:187-220.
32. Mickey RM, Greenland S: The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989, 129:125-137.
33. Triantafillidis JK, Emmanouilidis A, Manousos ON, Nikolakis D, Kogevinas M: Clinical patterns of Crohn's disease in Greece: a follow-up study of 155 cases. Digestion 2000, 61:121-128.
34. Emmanouilidis A, Manousos ON, Papadimitriou C, Triantafillidis JK: Ulcerative colitis in Greece: course and prognostic factors. Digestion 1988, 39:181-6.
35. Manousos ON, Triantafillidis JK, Emmanouilidis A, Papademitriou C: Ulcerative colitis in Greece. Epidemiological and clinical data. Scand J Gastroenterol 1989, 170:25-6.
36. Triantafillidis JK, Emmanouilidis A, Manousos ON, Pomonis E, Tsitsa C, Cheracakis P, Barbatzas C: Ulcerative colitis in Greece: clinicoepidemiological data, course, and prognostic factors in 413 consecutive patients. J Clin Gastroenterol 1998, 27:204-210.
37. Archimandritis AJ, Kourcesas D, Sougioultzis S, Giontzis A, Grigoriadis P, Davaris P, Tzivras M: Inflammatory bowel disease in Greece - a hospital based clinical study of 172 consecutive patients. Med Sci Monit 2002, 8:CR 158-64.
38. Zankel E, Rogler G, Andus T, Reng CM, Scholmerich J, Timmer A: Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort. Eur J Gastroenterol Hepatol 2005, 17:395-401.
39. Kelly JK, Sutherland LR: The chronological sequence in the pathology of Crohn's disease. J Clin Gastroenterol 1988, 10:28-33.
40. Picco MF, Bayless TM: Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviours in the first 8 years of Crohn's disease. Am J Gastroenterol 2003, 98:363-368.
41. Sachar DB: Behaviour of Crohn's disease according to the Vienna classification. Gut 2002, 51:614-615.
42. Papi C, Festa V, Fagnani C, Stazi A, Antonelli G, Moretti A, Koch M, Capurso L: Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Dig Liver Dis 2005, 37:247-253.
43. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP: Effect of smoking on the long term course of Crohn's disease. Gastroenterology 1996, 110:424-431.
44. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, Traina M, Tonelli F, Pagliaro L: Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994, 106:643-648.
45. Lindberg E, Jarnerot G, Huitfeldt B: Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992, 33:779-782.
46. Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF,Shivananda S, Stockbrugger RW: Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD study Group. Inflamm Bowel Dis 1998, 4:182-6.
47. Brant SR, Picco MF, Achar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH: Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003, 9:281-289.
48. Munkholm P, Langholz E, Davidsen M, Binder V: Intestinal cancer risk and mortality in patients with Crohn's disease. Gostroenterology 1993, 105:1716-1723.
49. Veloso FT, Ferreira JT, Barros L, Almeida S: Clinical outcome of Crohn's disease: Analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001, 7:306-313.
50. Agrez MV, Valente RM, Pierce W, Melton J 3rd, van Heerden JA, Beart RW Jr: Surgical history of Crohn's disease in a well-defined population. Mayo Clin Proc 1982, 57:742-752.
51. Silverstein MD, Loftus EV, Sandborn WJ, Tremaine Wj, Feagan BG, Nietert PJ, Harmsen WS, Zinsmeister AR: Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999, 117:49-57.
52. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J: Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Phormacol Ther 1999, 13:1403-1411.
53. Chardavoyne R, Flint GW, Pollack S, Wise L Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986, 29:495-502.
54. Binder V, Hendriksen C, Kreiner S: Prognosis in Crohn's disease based on results from regional patient group from the county of Copenhagen. Gut 1985, 26:146-150.
55. Sands BE, Arsenault JE, Rosen MJ, Alsahli M, Bailen M, Banks P,Bensen S, Bousvaros A, Cave D, Cooley JS, Cooper HL, Edwards ST, Farrell RJ Griffin MJ, Hay DW, John A, Lidofsky S, Olans LB, Peppercorn MA, Rothstein RI, Roy MA, Saletta MJ, Shah SA, Warner AS, WolfJ L, Vecchio J, Winter HS, Zawacki JK: Risk of early surgery for Crohn's disease: Implications for early treatment strategies. Am J Gastroenterol 2003, 98:2712-2718.
56. Nordgren SR, Fasth SB, Oresland TO, Hulten LA: Long-term follow up in Crohn's disease. Scand J Gastroenterol 1994, 11:22-28.
57. Aeberhard P, Berchtold W, Riedtmann HJ, Stadelmann G: Surgical recurrence of peforating and nonperforating Crohn's disease - a study of 101 surgically treated patients. Dis Colon Rectum 1996, 39:80-87.
58. Lautenbach E, Berlin JA, Lichtenstein GR: Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998, 115:259-267.
59. Hamon JF, Carbonnel F, Beaugerie L, Sezeur A, Gallot D, Malafosse M, Parc R, Gendre JP, Cosnes J: Comparison of long-term course of perforating and non-perforating Crohn's disease. Gastroenterol Clin Biol 1998, 22:601-606.
60. Yamamoto T, Allan RN, Keighley MR: Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease. Dis Colon Rectum 1999, 42:519-524.
61. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR: Marker antibody expression stratifies Crohn's disease into immunologically homogenous subgroups with distinct clinical characteristics. Gut 2000, 47:487-496.
62. Bell SJ, Williams AB, Wisel P, Wilkinson K, Cohen RC, Kamm MA: The clinical course of fistulating Crohn's disease. Aliment Pharmocal Ther 2003, 17:1145-1151.
63. Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, van Hogezand RA, Annese V, Schneider J, Korelitz BI, Cosnes J, Task Force on Clinical Phenotyping of the IOIBD: Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol 2005, 100:1547-1549.
64. Langholz E, Munkholm P, Davidsen M, Binder W: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992, 103:1444-51.
65. Leijonmarck CE, Persson PG, Hellers G: Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990, 31:329-333.
66. Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.